You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 17, 2024

PRELUDIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Preludin, and when can generic versions of Preludin launch?

Preludin is a drug marketed by Boehringer Ingelheim and is included in two NDAs.

The generic ingredient in PRELUDIN is phenmetrazine hydrochloride. Additional details are available on the phenmetrazine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PRELUDIN?
  • What are the global sales for PRELUDIN?
  • What is Average Wholesale Price for PRELUDIN?
Summary for PRELUDIN
US Patents:0
Applicants:1
NDAs:2
Raw Ingredient (Bulk) Api Vendors: 50
Patent Applications: 4,047
DailyMed Link:PRELUDIN at DailyMed
Drug patent expirations by year for PRELUDIN

US Patents and Regulatory Information for PRELUDIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim PRELUDIN phenmetrazine hydrochloride TABLET, EXTENDED RELEASE;ORAL 011752-004 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Boehringer Ingelheim PRELUDIN phenmetrazine hydrochloride TABLET, EXTENDED RELEASE;ORAL 011752-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Boehringer Ingelheim PRELUDIN phenmetrazine hydrochloride TABLET;ORAL 010460-005 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.